These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
451 related items for PubMed ID: 16776915
21. [Atrial fibrillation and apoplexy--risks and prevention]. Koefoed BG, Gulløv AL, Petersen P. Nord Med; 1996 Jun; 111(6):171-5. PubMed ID: 8700641 [Abstract] [Full Text] [Related]
22. [Atrial fibrillation and thromboembolic events prevention. State of the art]. Matteoli S, Trappolini M, Chillotti FM. Minerva Cardioangiol; 2001 Feb; 49(1):1-13. PubMed ID: 11279381 [Abstract] [Full Text] [Related]
23. A randomised controlled trial of warfarin versus aspirin for stroke prevention in octogenarians with atrial fibrillation (WASPO). Rash A, Downes T, Portner R, Yeo WW, Morgan N, Channer KS. Age Ageing; 2007 Mar; 36(2):151-6. PubMed ID: 17175564 [Abstract] [Full Text] [Related]
24. Status of antithrombotic therapy for patients with atrial fibrillation in university hospitals. Albers GW, Yim JM, Belew KM, Bittar N, Hattemer CR, Phillips BG, Kemp S, Hall EA, Morton DJ, Vlasses PH. Arch Intern Med; 1996 Nov 11; 156(20):2311-6. PubMed ID: 8911237 [Abstract] [Full Text] [Related]
25. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. Chimowitz MI, Lynn MJ, Howlett-Smith H, Stern BJ, Hertzberg VS, Frankel MR, Levine SR, Chaturvedi S, Kasner SE, Benesch CG, Sila CA, Jovin TG, Romano JG, Warfarin-Aspirin Symptomatic Intracranial Disease Trial Investigators. N Engl J Med; 2005 Mar 31; 352(13):1305-16. PubMed ID: 15800226 [Abstract] [Full Text] [Related]
26. Factors affecting bleeding risk during anticoagulant therapy in patients with atrial fibrillation: observations from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study. DiMarco JP, Flaker G, Waldo AL, Corley SD, Greene HL, Safford RE, Rosenfeld LE, Mitrani G, Nemeth M, AFFIRM Investigators. Am Heart J; 2005 Apr 31; 149(4):650-6. PubMed ID: 15990748 [Abstract] [Full Text] [Related]
27. Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators. Ezekowitz MD, Bridgers SL, James KE, Carliner NH, Colling CL, Gornick CC, Krause-Steinrauf H, Kurtzke JF, Nazarian SM, Radford MJ. N Engl J Med; 1992 Nov 12; 327(20):1406-12. PubMed ID: 1406859 [Abstract] [Full Text] [Related]
28. Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice? Go AS, Hylek EM, Chang Y, Phillips KA, Henault LE, Capra AM, Jensvold NG, Selby JV, Singer DE. JAMA; 2003 Nov 26; 290(20):2685-92. PubMed ID: 14645310 [Abstract] [Full Text] [Related]
29. Apixaban for reduction in stroke and other ThromboemboLic events in atrial fibrillation (ARISTOTLE) trial: design and rationale. Lopes RD, Alexander JH, Al-Khatib SM, Ansell J, Diaz R, Easton JD, Gersh BJ, Granger CB, Hanna M, Horowitz J, Hylek EM, McMurray JJ, Verheugt FW, Wallentin L, ARISTOTLE Investigators. Am Heart J; 2010 Mar 26; 159(3):331-9. PubMed ID: 20211292 [Abstract] [Full Text] [Related]
30. Predictors of warfarin use in atrial fibrillation patients in the inpatient setting. Agarwal S, Bennett D, Smith DJ. Am J Cardiovasc Drugs; 2010 Mar 26; 10(1):37-48. PubMed ID: 20104933 [Abstract] [Full Text] [Related]
31. [The efficacy and safety of antithrombotic therapy with warfarin in nonrheumatic atrial fibrillation]. Antithrombotic Therapy in Atrial Fibrillation Study InvestigatesCardiology Department of Peking University People's Hospital, Beijing 100044, China., Hu DY. Zhonghua Nei Ke Za Zhi; 2006 Oct 26; 45(10):800-3. PubMed ID: 17217741 [Abstract] [Full Text] [Related]
32. Stroke and bleeding in atrial fibrillation with chronic kidney disease. Olesen JB, Lip GY, Kamper AL, Hommel K, Køber L, Lane DA, Lindhardsen J, Gislason GH, Torp-Pedersen C. N Engl J Med; 2012 Aug 16; 367(7):625-35. PubMed ID: 22894575 [Abstract] [Full Text] [Related]
33. Fecal hemoglobin excretion in elderly patients with atrial fibrillation: combined aspirin and low-dose warfarin vs conventional warfarin therapy. Blackshear JL, Baker VS, Holland A, Litin SC, Ahlquist DA, Hart RG, Ellefson R, Koehler J. Arch Intern Med; 1996 Mar 25; 156(6):658-60. PubMed ID: 8629878 [Abstract] [Full Text] [Related]
34. Frequency and effect of optimal anticoagulation before onset of ischaemic stroke in patients with known atrial fibrillation. Indredavik B, Rohweder G, Lydersen S. J Intern Med; 2005 Aug 25; 258(2):133-44. PubMed ID: 16018790 [Abstract] [Full Text] [Related]
35. Risk of major bleeding with concomitant dual antiplatelet therapy after percutaneous coronary intervention in patients receiving long-term warfarin therapy. DeEugenio D, Kolman L, DeCaro M, Andrel J, Chervoneva I, Duong P, Lam L, McGowan C, Lee G, DeCaro M, Ruggiero N, Singhal S, Greenspon A. Pharmacotherapy; 2007 May 25; 27(5):691-6. PubMed ID: 17461704 [Abstract] [Full Text] [Related]
36. Risk factors for bleeding during anticoagulation of atrial fibrillation in older and younger patients in clinical practice. Abdelhafiz AH, Wheeldon NM. Am J Geriatr Pharmacother; 2008 Mar 25; 6(1):1-11. PubMed ID: 18396243 [Abstract] [Full Text] [Related]
37. Safety and effectiveness of antithrombotic strategies in older adult patients with atrial fibrillation and non-ST elevation myocardial infarction. Fosbol EL, Wang TY, Li S, Piccini JP, Lopes RD, Shah B, Mills RM, Klaskala W, Alexander KP, Thomas L, Roe MT, Peterson ED. Am Heart J; 2012 Apr 25; 163(4):720-8. PubMed ID: 22520540 [Abstract] [Full Text] [Related]